Supporting the impact of p53 alterations on tumor biological aggressiveness is the statistically significant association of the MC with both p53 staining and TP53 mutation. However, it should be noted that in our study, 10 out of 15 cases with a TP53 mutation did not exhibit p53 overexpression at the immunohistochemical level. Here, TP53 is linked to neoplasm.